『Celecoxib & natural product combination osteoarthritis treatment “Celecaduo Tablet” launched』
KyungDong Pharm Co., Ltd. will launch “Celecaduo Tablet,” a combination osteoarthritis treatment of celecoxib and natural products, in November.
"Selecca Duo Tablet" is a combination of 100 mg of celecoxib and 25% ethanol-softened extract of angelica root, quince, windbreak, sokdan, sycamore, eucalyptus, eulyeongseon, yukgye, jingyo, cheongung, cheonma, and safflower.
"Selekka Duo Tablet" proved to be superior to the control group in the change in 100mm pain VAS, the primary efficacy endpoint, as a result of clinical trials targeting patients with knee osteoarthritis.
In addition, as a result of measuring the pain improvement level of the combination drug compared to the control group for 8 weeks in patients, it was proven that the pain improvement level was superior to the control group.
The elderly population is expected to reach 35.6% in 2045, and the number of people with osteoarthritis symptoms is also expected to increase.
KyungDong Pharm Co., Ltd.'s launch of "Selekka Duo Tablet" is expected to provide an effective direction for the treatment of patients with osteoarthritis.
※ Product information
▶ Product name: Selecta Duo tablets
▶ Ingredient content: Celecoxib 100mg/ angelica root, quince, windbreak, sokdan, sycamore, sycamore, eulyeongseon, broiler, jingyo, cheongung, cheonma, safflower 25% ethanol soft extract
▶ Efficacy: Relieves symptoms of osteoarthrosis
▶ Dosage: 2 times a day, 1 tablet per time
▶ Insurance drug price: 567 won / tablet
▶ Packaging unit: 30 tablets, 300 tablets
▶ Remarks: Please refer to the product manual for other details such as precautions for use.
?